QuidelOrtho QDEL
NASDAQ QDEL
$14.74 -0.11 (-0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2026)

QuidelOrtho (QDEL) posted Cash from Financing Activities of $37.6 million for Q1 2026, up 438.74% sequentially from -$11.1 million in Q4 2025, and up 113.64% YoY from $17.6 million in Q1 2025.

QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2026) Analysis & Trends

QuidelOrtho has reported Cash from Financing Activities for 6 years, with the latest figure at $37.6 million in Q1 2026.

  • Quarterly Cash from Financing Activities rose 113.64% year-over-year to $37.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175.8 million (up 107.07% YoY) and the FY2025 annual result came in at $155.8 million, up 219.26% from the prior year.
  • Cash from Financing Activities grew to $37.6 million in Q1 2026 per QDEL's latest filing, from -$11.1 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $424.2 million in Q1 2023 and troughed at -$99.7 million in Q3 2023.
  • A 5-year average of $26.5 million and a median of -$11.1 million in 2025 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities slumped 1652.94% in 2023, then soared 274.9% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$3.4 million in 2022, then sank by 1600.0% to -$57.8 million in 2023, then slipped by 19.2% to -$68.9 million in 2024, then jumped by 83.89% to -$11.1 million in 2025, then surged by 438.74% to $37.6 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $37.6 million, -$11.1 million, and $46.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 QuidelOrtho 1.01 Bn 885.73 Mn - 200.60 Mn

Historic Data

Download Data
DateValue
Jun 28, 2026 200.60 Mn
Jun 28, 2026 200.60 Mn
Mar 29, 2026 37.60 Mn
Mar 29, 2026 37.60 Mn
Dec 28, 2025 -11.10 Mn
Dec 28, 2025 -11.10 Mn
Sep 28, 2025 46.00 Mn
Sep 28, 2025 46.00 Mn
Jun 29, 2025 103.30 Mn
Jun 29, 2025 103.30 Mn
Mar 30, 2025 17.60 Mn
Mar 30, 2025 17.60 Mn
Dec 29, 2024 -68.90 Mn
Dec 29, 2024 -68.90 Mn
Sep 29, 2024 -26.30 Mn
Sep 29, 2024 -26.30 Mn
Jun 30, 2024 162.50 Mn
Jun 30, 2024 162.50 Mn
Mar 31, 2024 -18.50 Mn
Mar 31, 2024 -18.50 Mn